Uncommon Bio
4 known investors
Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.
Investors · 4
In the news
Frequently asked questions
- What does Uncommon Bio do?
- Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.
- Who are Uncommon Bio's investors?
- Uncommon Bio's investors include Angel Academe, Balderton Capital, Global Brain, redalpine.